Toxins produced by microbial species have a direct effect on the brain but can also produce indirect effects on neurotransmitter synthesis and cause neuro-inflammation. This webinar will focus on the mechanism of action that Candida and Clostridia have on the brain as well as the treatment options that are most likely to succeed.
The Other Side of Methylation – Imbalances In Serotonin, Tryptophan and Others As They Relate To the Organic Acids Test
Methylation is a topic of great interest in autism, mental health disorders and other chronic health problems. Most of the attention is focused on MTHFR C667T polymorphisms, but there are other biochemical imbalances linked to methylation, such as that with serotonin, that can adversely affect neurochemistry. This lecture will explore these areas as they relate to various health conditions.
The use of herbs in healing traditions was prevalent during ancient times across several cultures. Scientists are now revisiting the use of plant-based herbs in the treatment of illnesses such as depression, where it has been shown to exhibit positive effects on neurochemistry. Some research has demonstrated the ability of botanicals to effectively augment treatment responses in depressed patients with unresolved symptoms. In this webinar, Dr. James Greenblatt will review the indications and side effect profile of commonly used botanicals in the treatment of depression including St. John’s wort, Rhodiola rosea, and curcumin. Following this presentation, participants will gain a better understanding of how to incorporate botanicals as part of an integrative approach.
Thyroid dysfunction, particularly hypothyroidism, affects millions of people worldwide. The thyroid plays a critical role in cellular metabolism and overall health. However, many individuals suffer from poor thyroid functions because of adrenal hormone issues. This presentation will explore the link between these two systems.
Each year, it has been reported that 1 in 5 females and 1 in 7 males engage in self-harming behaviors; and approximately 90 percent of this population began self-harm behaviors during adolescence or pre-teen years. The statistics illustrate an alarming and present danger for vulnerable populations for an increased risk of suicide, particularly adolescents struggling with depression, anxiety, and substance abuse disorders. In this webinar, Dr. James Greenblatt will present pharmacological and nutritional interventions to reduce self-harm behaviors and suicide risk. A review of the literature examining examining factors contributing to increased suicide risk including omega-3 fatty acid deficiencies and low cholesterol will also be discussed.
The Neurotransmitter Metabolites of the Organic Acids Test: Clinical Significance and Practical Application of Genetics
The nuances of the neurotransmitter section of the Organic Acids Test are often misunderstood. Both elevations and deficits of these metabolites are highly influenced by genetics, drugs, microbial landscape, and amino acid availability. Jessica Bonovich, R.N., B.S.N., consultant for The Great Plains Laboratory will explain each of these factors and provide examples in support.
Certain environmental chemicals can lead to a variety of health disorders. The link to autism-spectrum disorders is becoming more widely accepted even in mainstream circles where certain chemicals have been correlated with increased rates of autism diagnosis. This presentation will explore various environmental chemicals and testing options.
Individuals with autism often have many underlying biological problems which contribute to their difficulties. This presentation, geared toward the parent or caregiver with a newly diagnosed child, will explain what many of these problems are and how biomedical intervention can improve the long-term outcome of a child’s health.
The increasing global prevalence of ADHD diagnoses has been found to be directly correlated with an increased consumption of ADHD medication. In light of the worldwide rise of ADHD rates, recent reports also illustrate how conventional treatment approaches fail at correcting a poorly understood disorder. In this webinar, Dr. James Greenblatt will review how nutritional deficiencies, metabolic errors, and environmental exposures may exacerbate ADHD symptoms and impede treatment. Vitamin and mineral co-factors that are critical for the synthesis of serotonin and dopamine and receptor function will also be discussed. Following this presentation, participants will be able implement a comprehensive treatment plan with nutritional augmentation strategies to minimize side effects and enhance outcomes.
Prescription medications are sometimes used to improve mood, sleep and behavior problems for individuals with autism spectrum disorders. This presentation will discuss many of these medications, how they are used, their mechanism of action and dosing suggestions.
In this webinar, Dr. Pratt-Hyatt will review the new chemicals that have just been added to our toxic organic chemical profile, GPL-TOX, and why it’s so important to have them tested. These chemicals include those used in common plasticizers, coatings, flame retardants, rubber products, food packaging, cosmetics, as well as those released from cigarette smoke and even in the treatment of drinking water. He will also present recommended treatments for detoxifying the body of these chemicals.
Gut flora is critical for our health, not only in the digestive system, but throughout the body. Various bacterial strains have specific function in providing protection against pathogens, but also promote various physiological processes critical for optimal health. This presentation will explore some of these concepts.
Several patients experience a phenomenon known as “Medication Discontinuation Syndrome” while tapering off antidepressant medications. Because antidepressants essentially alter the function and production of the mood-regulating substances in brain, abruptly stopping medications does not allow for the brain to adjust to rapid changes, leading to uncomfortable and sometimes dangerous side effects. The webinar will provide a comprehensive guide to achieve a safe and successful taper. This webinar will also discuss nutritional interventions including essential fatty acids, amino acid precursors, B vitamins, and other trace minerals to minimize medication withdrawal symptoms.
Mental Health, Methylation, and You: How Our New Genetic Test Helps You Understand Your Mental Health Risks
This webinar will review the most important genes for mental health and specific mutations in those genes, which are analyzed by the GPL-SNP1000 DNA Sequencing Profile. For mental health, we specifically analyze 88 SNPs (single-nucleotide polymorphisms) across 14 different genes. Other pertinent gene groups for mental health, including those for autism risk and drug metabolism/toxification will also be reviewed.
Mitochondria are the powerhouse of cellular energy production. However, they are vulnerable to various stressors, i.e. toxins and infections which compromise their function. This presentation will focus on common factors adversely affecting mitochondria and natural ways to improve mitochondria activity through supplement support and exercise.
Binge eating disorder is the most common eating disorder in the United States, affecting 3.5% of women, 2% of men, and up to 1.6% of adolescents. The increasing number of individuals struggling with obesity and food addiction reflects a growing need for professionals to adequately diagnose and effectively treat these conditions. This webinar will present evidence-based strategies to augment the treatment of binge eating disorder including amino acids, digestive enzymes, vitamins, and trace minerals.
The production of Secretory IgA is important for overall immune health. This presentation will focus on ways to improve digestive immune function.
Eating disorders are often difficult to treat with minimal, proven effective pharmacological interventions. A published review of nearly fifty years of research also found that individuals with eating disorders have the highest mortality rates of any psychiatric disorder. While eating disorders initially present as preoccupation with food and weight, they ultimately become brain-based disorders marked by profound malnutrition. In this webinar, Dr. Greenblatt will present new research highlighting the benefits of how nutritional supplementation including zinc and essential fatty acids can enhance treatment outcomes.
Many bacteria and candida infections are complicated enough to treat, but add in their production of biofilm and some of these infections become even more challenging. This lecture will explore the pathogenicity of biofilm and various strategies to deal with them.
Lab testing can be a critical piece to understanding and treating the underlying biomedical issues related to autism. As a parent, you have many things to consider when evaluating lab testing, including cost, method of testing (whether it is blood, urine, hair, or saliva), usefulness, and the possible benefits of it. Understanding these aspects of testing is important for parents to make informed decisions about whether to test and what to test. Terri will walk you through some of the major things that contribute to a parent's use and understanding of diagnostic testing, including how to help educate care providers on your team about testing.
Candida and various bacteria all produce biofilm as a protective mechanism for their own survival. What are some of the other reasons for biofilm and how do they increase a candida and bacteria pathogenicity? This lecture will explore these questions.
There are many parasites we can be exposed to through contaminated water and food products. This lecture will discuss the more common parasite infections such as Giardia, Cryptosporidium and Blastocystis hominis, what tests are available for detection, and treatment options for eradication.
Helicobacter pylori (H. pylori) is a complex bacteria that can cause significant digestive problems. This presentation will look at the role of H. pylori in certain digestive disorders and various interventions that can be helpful for its eradication.
Personalized medicine is the future of healthcare. Our new genetic test, GPL-SNP1000 will provide the information that patients and healthcare practitioners need to design the best course of care. GPL-SNP1000 tests over 140 genes and over 1,000 SNPs in 9 specific pathways. This presentation will provide an overview of the new test and why each of the pathways it analyzes is important for a patient’s health. These pathways include: DNA methylation, mental health, autism risk, oxalate metabolism, gluten sensitivity, cholesterol biosynthesis, and transporters.